In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
The ESC Guidelines on Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death on ESC TV

Watch the discussion between Philippe H Kolh, Silvia Giuliana Priori and Dirk Van Veldhuisen.

Watch the esc TV Interview
ESC Pocket Guidelines App

Get all the latest ESC Pocket Guidelines, plus interactive tools (algorithms, calculators, charts, scores...) in your pocket.

ESC Webinar: Ventricular arrhythmias and sudden cardiac death

what's new in the 2015 ESC Guidelines?

Watch the webinar recording

Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

ESC Clinical Practice Guidelines

Sudden Cardiac Death and Resuscitation
Acute Cardiac Care
Guidelines version available to download
Published in2015
ReferenceEuropean Heart Journal, doi/10.1093/eurheartj/ehv316
Published in2015
Referencedoi/10.1093/eurheartj/ ehv316
Published in2015
Reference36 CME Questions
Published in2015
ReferencePocket Guidelines on VA and SCD
  • PDA
  • Published in2015
    ReferenceDownload the ESC Pocket Guidelines App
    Published in2006
    ReferenceEHJ 2006;27:2099–2140
    Published in2006
    ReferenceEuropace (2006) 8, 746–837; doi:10.1093/europace/eul108
    Table of contents: Full Text (ESC Clinical Practice Guidelines)

    1. Preamble
    2. Introduction
    2.1 Structure of the guidelines
    3. Definitions, epidemiology and future perspectives for the
    prevention of sudden cardiac death
    3.1 Epidemiology of sudden cardiac death
    3.2 Indications for autopsy and molecular autopsy in sudden death victims
    3.3 Risk prediction of sudden cardiac death
    3.4 Prevention of sudden cardiac death in special settings
    4. Therapies for ventricular arrhythmias
    4.1 Treatment of underlying heart disease
    4.2 Pharmacotherapy for ventricular arrhythmia and prevention of sudden cardiac death
    4.3 Device therapy
    4.4 Cardioversion or defibrillation and acute treatment of sustained ventricular arrhythmias
    4.5 Interventional therapy
    4.6 Psychosocial impact of implantable cardioverter defibrillator treatment
    5. Management of ventricular arrhythmias and prevention of sudden cardiac death in coronary artery disease
    5.1 Acute coronary syndromes
    5.2 Early after myocardial infarction
    5.3 Stable coronary artery disease after myocardial infarction with preserved ejection fraction
    6. Therapies for patients with left ventricular dysfunction, with or without heart failure
    6.1 Primary prevention of sudden cardiac death
    6.2 Premature ventricular complexes in patients with structural heart disease/left ventricular dysfunction
    6.3 Sustained ventricular tachycardia
    7. Cardiomyopathies
    7.1 Dilated cardiomyopathy
    7.2 Hypertrophic cardiomyopathy
    7.3 Arrhythmogenic right ventricular cardiomyopathy  
    7.4 Infiltrative cardiomyopathies
    7.5 Restrictive cardiomyopathy
    7.6 Other cardiomyopathies
    8. Inherited primary arrhythmia syndromes
    8.1 Long QT syndrome
    8.2 Short QT syndrome
    8.3 Brugada syndrome
    8.4 Catecholaminergic polymorphic ventricular tachycardia
    8.5 Early repolarization syndrome
    9. Paediatric arrhythmias and congenital heart disease
    9.1 Management of ventricular arrhythmias in children with a structurally normal heart
    9.2 Sudden cardiac death and ventricular arrhythmias in patients with congenital heart disease
    9.3 Implantable cardioverter defibrillator therapy in paediatric patients
    10. Ventricular tachycardias and ventricular fibrillation in structurally normal hearts
    10.1 Outflow tract ventricular tachycardias
    10.2 Ventricular tachycardias of miscellaneous origin
    10.3 Idiopathic ventricular fibrillation
    10.4 Short-coupled torsade de pointes
    11. Inflammatory, rheumatic and valvular heart diseases
    11.1 Myocarditis
    11.2 Endocarditis
    11.3 Rheumatic heart disease .
    11.4 Pericarditis
    11.5 Cardiac sarcoidosis
    11.6 Valvular heart disease
    12. Arrhythmic risk in selected populations
    12.1 Psychiatric patients
    12.1.1 Epidemiology
    12.1.2 Diagnosis
    12.1.3 Treatment
    12.2 Neurological patients
    12.3 Pregnant patients
    12.4 Obstructive sleep apnoea
    12.5 Drug-related pro-arrhythmia  
    12.6 Sudden cardiac death after heart transplantation
    12.7 Sudden cardiac death in athletes
    12.8 Wolff–Parkinson–White syndrome
    12.9 Prevention of sudden cardiac death in the elderly
    12.10 End-of-life issues
    13. Gaps in evidence
    14. To do and not to do messages from the guidelines




    Back to top